Peter Ros is an experienced finance and operations professional currently serving as the Vice President Finance at LAVA Therapeutics N.V. and VP Finance & Operations at Scenic Biotech. With a robust background in the international Life Science and Biotechnology sectors, Peter has previously held senior roles, including Sr. Director Finance & Accounting at Genmab and Interim Controller at Vanenburg Software. Peter is also a non-executive board member at Blue21 and an associate at IMRA Netwerk, emphasizing a commitment to high business ethics and reliable results throughout their career. Peter holds degrees from Vrije Universiteit Amsterdam and Windesheim and is actively involved in ongoing education at Alex van Groningen and Maastricht University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices